| NCT ID | NCT06035939 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Sickle Cell Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 272 participants |
| Start Date | 2024-04-04 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 272 participants in total. It began in 2024-04-04 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to find out whether a web-based intervention using a mobile app is helpful for teens and young adults with sickle cell disease (SCD) in learning how to care for and manage their symptoms.
Eligibility Criteria
Inclusion Criteria: * documentation in the electronic health record of any type of SCD * owns mobile device compatible with the intervention * access to the internet Exclusion Criteria: * Plans to relocate outside of study site area in the next 12 months * Plans to transition to adult care in 12 months or less * Parent/caregiver or provider report of neurocognitive impairment that precludes ability to use intervention and participate in study * non-English speaking
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06035939 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 21 Years, studying Sickle Cell Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06035939 currently recruiting?
Yes, NCT06035939 is actively recruiting participants. Contact the research team at phillipss@musc.edu for enrollment information.
Where is the NCT06035939 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT06035939 clinical trial?
NCT06035939 is sponsored by Medical University of South Carolina. The trial plans to enroll 272 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.